Experimental study to evaluate the usefulness of S-1 in a model of peritoneal dissemination of gastric cancer
- 190 Downloads
Favorable results have been reported for the novel oral anticancer agent S-1 (TS-1®) in clinical studies of advanced gastric cancer with peritoneal dissemination. In the present study we assessed its pharmacokinetics, inhibitory effects, and effect on survival time in an animal model.
A model of peritoneal dissemination was created by intraperitoneally implanting 4-week-old female BALBc nu/nu mice with the human gastric cancer cell line MKN-45 after transfection with a fluorescent protein-expressing vector. Pharmacokinetics were investigated by measuring intratumor, peritoneal lining, and blood concentrations after the administration of S-1 and fluorouracil (5-FU). The effect of S-1 on survival time was also assessed, by administration once daily to seven animals per group, starting on day 7 after implantation, and survival time was compared with that of an untreated control group. The inhibitory effect of S-1 on peritoneal dissemination was evaluated by killing mice at the start of administration, and 1 and 3 weeks after the start of administration, and examining them for the presence of peritoneal dissemination under a fluorescence stereomicroscope.
Maintenance of high 5-FU concentrations in the intraperitoneal tumors was confirmed in the S-1 group, and survival time was prolonged without any decrease in oral food intake or body weight.
Assessment in a model of peritoneal dissemination of gastric cancer showed that the novel oral anticancer agent S-1 was effective against peritoneal dissemination, and that it improved the survival rate.
Key wordsGastric cancer Peritoneal dissemination S-1
- 9.Shirasaka, T, Shimamoto, Y, Ohshimo, H, Yamaguchi, M, Kato, T, Yonekura, K, Fukushima, M 1996Development of a novel form of an oral 5-fluorouracil derivative (S-1) directed to the potential of the tumor selective cytotoxicity of 5-fluorouracil by two biochemical modulatorsAnticancer Drugs754857PubMedGoogle Scholar
- 14.Unemi, N, Takeda, S, Tajima, K, Kawaguchi, Y, Yasuda, A 1981Effect of coadministration of uracil on the antitumor activity of 1-(Terahydro-2-furanyl)-5-fluorouracil and the level of 5-fluorouracil in AH 130 bearing RatsChemotherapy2916475Google Scholar
- 15.Matsushima, E, Yoshida, K, Kitamura, R, Yoshida, K 1997Determination of S-1 (combined drug of tegafur, 5-chloro-2,4-dihydroxypyridine and potassium oxonate) and 5-fluorouracil in human plasma and urine using high-performance liquid chromatography and gas chromatography-negative ion chemical ionization mass spectrometryJ Chromatogr B69195104Google Scholar